Complexin prevents SNAREs from releasing neurotransmitters until an action potential arrives at the synapse. To understand the mechanism for this inhibition, we determined the structure of complexin bound to a mimetic of a prefusion SNAREpin lacking the portion of the v-SNARE that zippers last to trigger fusion. The 'central helix' of complexin is anchored to one SNARE complex, while its 'accessory helix' extends away at ~45° and bridges to a second complex, occupying the vacant v-SNARE binding site to inhibit fusion. We expected the accessory helix to compete with the v-SNARE for t-SNARE binding but found instead that the interaction occurs intermolecularly. Thus, complexin organizes the SNAREs into a zigzag topology that, when interposed between the vesicle and plasma membranes, is incompatible with fusion.
Release of neurotransmitter at the synapse must be timed precisely to immediately follow the arrival of a nervous impulse. The physiological and anatomical mechanisms for this have long been known 1, 2 . Synaptic vesicles containing neurotransmitter are already docked at the 'active zones' of the presynaptic membrane, ready to respond to the elevated calcium levels that accompany an action potential by releasing neurotransmitter.
In recent years, much has also been learned about the molecular mechanisms underlying this physiology. The central players in neurotransmitter release are the SNARE proteins 3 . These are the engines that drive membrane fusion between cargo-carrying vesicles and the plasma membrane 4, 5 , as v-SNAREs (anchored in the vesicle membrane) zipper into a coiled-coil four-helix bundle with cognate t-SNAREs (anchored in the plasma membrane) [3] [4] [5] [6] . In synapses, a major v-SNARE is VAMP2, and the t-SNARE proteins are SNAP25 and syntaxin1, where VAMP2 and syntaxin1 each contribute one helix to the coiled coil and SNAP25 contributes two 7 . Another vital component is synaptotagmin, a synaptic vesicle protein 8 that binds calcium ions 9 and is the immediate sensor and trigger for vesicle fusion [10] [11] [12] . How precisely synaptotagmin couples to SNAREs to trigger fusion remains unknown.
Whatever the mechanism, rapid and synchronous release of neurotransmitter requires that the fusion process by SNARE proteins be frozen in place, or 'clamped' 3 , when it is well advanced. This is because fusion by SNARE proteins is spontaneous 4, 5 and must therefore be inhibited to prevent continuous release of neurotransmitters. This is also because neurotransmitter release takes place on a much shorter time scale than the entire process of vesicle docking and fusion complex assembly. For example, fusion of artificial vesicles bearing v-SNAREs to planar lipid bilayers containing t-SNAREs requires 10-100 ms following docking [13] [14] [15] , whereas neurotransmitter release can take place in 1 ms or less after calcium entry. Thus, fusion must be clamped at a very late stage in synapses.
A combination of biochemical, genetic and physiological results have clearly pinpointed complexin (CPX) 16, 17 as the central component of this clamp [18] [19] [20] . Because CPX both facilitates and inhibits synaptic fusion [21] [22] [23] [24] [25] [26] , it has been proposed to act by catalyzing the initial stages of SNARE assembly but then clamping further assembly until the arrival of an action potential (reviewed in ref. 27 ).
Structures of CPX bound to a postfusion fully assembled SNAREpin 28, 29 yielded the first insights regarding the facilitatory mechanism but did not resolve how CPX inhibits fusion. In the postfusion CPX-SNARE structures, CPX forms a continuous helix parallel to the SNAREpin coiled coil, with a central helix portion of CPX (CPX cen , residues 48-70 in human CPX1 (hCPX1)) contacting both the v-SNARE and t-SNARE in the membrane-distal portion of the SNAREpin. This is the portion of the SNAREpin that zippers first, and it is thus possible that CPX facilitates initial assembly 29 . The remainder of the CPX helix, termed its accessory helix (CPX acc , residues 26-47 in hCPX1), parallels the C-terminal membrane-proximal portion of the fully zippered SNARE complex but does not interact with it.
Nonetheless, the accessory helix is needed to create the clamped, prefusion state 21, 30 in which the membrane-distal N-terminal portions of the SNARE coiled-coil have zippered, but the membrane-proximal VAMP2 C terminus has not yet associated with the corresponding regions of SNAP25 and syntaxin1 (refs. 18,21,31-33) . Biochemical and spectroscopic experiments strongly support a mechanism whereby CPX acc directly competes with the VAMP2 C terminus for a r t i c l e s binding to the t-SNARE 19, 34 , but how this happens has been unclear in the absence of structural studies with prefusion SNARE complexes.
We have therefore designed a half-zippered soluble mimetic of the prefusion synaptic SNAREpin, and we have solved its structure when bound to complexin. Notably, we find that the CPX accessory helix extends away from the SNAREpin and binds a second SNAREpin to inhibit its assembly. Solution and functional studies confirm both the CPX conformation and the interaction between the accessory helix and prefusion SNAREpin observed in the structure. Our studies thus suggest that complexin cross-links prefusion SNARE complexes into a zigzag array. This array, when interposed between the vesicle and plasma membrane, provides a further barrier to fusion. Although cross-linking the CPX-SNARE array may block fusion, it also orients the SNAREs appropriately for fusion to proceed quickly upon clamp release.
RESULTS

Structures of a prefusion SNAREpin and its complex with CPX
The prefusion form of the SNARE complex is a transient intermediate stabilized in part by the simultaneous insertion of SNAREpins into two membrane bilayers, and hence is not readily accessible for structural studies. Zippering up begins as the prefolded N-terminal portions of VAMP2 associate with the preassembled t-SNARE complex [35] [36] [37] . In designing a soluble prefusion SNARE mimetic suitable for structural studies, we therefore prevented the completion of zippering by C-terminally truncating the VAMP2 SNARE motif. This SNARE complex (SNARE∆60) also contains residues 190-253 of rat Syntaxin 1A and residues 10-82 and 141-203 of human SNAP25A.
We determined the structure of this truncated SNARE complex at 2.2-Å resolution ( Table 1) . Except for the absent VAMP2 C terminus, the truncated SNARE complex in our studies superimposes well with fully assembled SNARE complexes studied previously (r.m.s. deviation 0.77-0.97 Å) 7, 29 . A notable finding is that the syntaxin1 and SNAP25 helices are almost fully formed even in the absence of the VAMP2 C terminus ( Fig. 1a) , suggesting that the t-SNAREs may be almost fully folded when the v-SNARE is only half-zippered.
We next co-crystallized SNARE∆60 with a CPX fragment (scCPX) consisting of its central and accessory helices (residues 26-83) and containing three 'superclamp' mutations (D27L E34F R37A) that increase its clamping efficiency both in vitro 19 and in vivo 38 . The structure was determined at 3.5 Å resolution using the truncated SNARE complex as a search model in the molecular replacement method ( Table 1) , and CPX was modeled into difference electron density. The final model includes residues 190-250 of syntaxin1, 10-74 and 141-203 of SNAP25, 29-60 of VAMP2 and 26-73 of CPX ( Fig. 1b) .
To confirm the sequence alignment along CPX, we used selenomethionine (SeMet)-substituted forms of scCPX in which residues Leu27 and Phe34 in the accessory helix were mutated to methionine (scCPX-L27M, scCPX-F34M). The SeMet-substituted forms of CPX were co-crystallized with the truncated SNARE complex, and anomalous data ( Table 1 ) were used to calculate difference maps that unambiguously locate the position of residues 27 and 34 as well as 55, a methionine in the wild-type sequence ( Supplementary Fig. 1 ). We also determined the structure of the SeMet-substituted scCPX-F34M bound to the truncated SNARE complex ( Table 1) . Although the crystals of this complex belong to a different spacegroup (P1) from the scCPX-SNARE crystals we initially obtained (C2), our findings regarding CPX-SNARE interactions are similar.
The CPX-SNARE∆60 structures resemble the fully zippered, postfusion structures observed previously in several aspects (Fig. 1c) . The conformations of the SNARE proteins are essentially unaltered a r t i c l e s (r.m.s. deviation 0.83 Å). Further, as in the postfusion forms of the CPX-SNARE complex 28, 29 and when it is alone in solution 39 , CPX forms a continuous helix. The interactions between CPX cen and the SNARE complex observed in the postfusion structure are also largely unperturbed (small positional shifts in CPX cen are detailed in Supplementary Table 1 ; see also Fig. 1c ). CPX cen binds in the groove between syntaxin1 and VAMP2, with critical residues Arg59, Arg63, Ile66, Tyr70 and Ile72 inserted into two high-affinity binding pockets observed in earlier studies 28, 29 . A third previously identified binding interface involves residues Asp64, Asp65 and Asp68 in the VAMP2 C terminus, which are missing in our construct. This interaction is not necessary for clamping 40 , so its absence in our structure probably will not affect conclusions regarding the CPX clamping mechanism. Despite these similarities, the arrangement of CPX relative to the SNAREs in our structure differs substantially from that in postfusion forms of the CPX-SNARE complex. The accessory helix undergoes a marked reorientation (r.m.s. deviation of CPX, compared to PDB 1KIL 29 , is 2.2 Å). Rather than running alongside the SNARE complex, CPX acc now bends away at a ~45° angle (Fig. 1c) . The reorientation likely results from small differences in CPX cen docking ( Supplementary Table 1 ) as well as small changes in φ and ψ torsion angles in the transition region between CPX cen and CPX acc (Supplementary Table 2 ). This result was unexpected given biochemical data indicating that CPX acc should occupy the binding site for the VAMP2 C terminus because CPX and the VAMP2 C terminus compete for binding to the t-SNAREs 19, 34 . Although CPX acc does not interact with the same SNARE complex bound by CPX cen , it does interact with a second, symmetry-related complex.
Overall, the crystal packing is such that CPX-SNARE complexes are arranged in a continuous zigzag ( Fig. 1d) , leaving the middle of the CPX helix entirely exposed to solvent. This region has high thermal motion, as evidenced by high B-factors ( Supplementary  Fig. 1 ). SNAREpins on opposite sides of the zigzag midline are related by a 180-degree rotation about (and a translation along) the midline. This means that on different sides of the midline, the linkers that connect the syntaxins and the VAMPs to their transmembrane helices in the plasma membrane and the synaptic vesicle, respectively, are on opposite sides of the zigzag plane. Although the CPX-F34M mutant crystallized in a different space group, it cross-links different SNARE complexes the same way, and the complexes are arranged in a zigzag ( Supplementary Fig. 2 ).
Residues at the N-terminal end of CPX acc (Leu27, Ala30, Ala31, Phe34 and Ala37) form a hydrophobic surface that binds to the t-SNARE in a second SNARE complex in a site normally occupied by the C terminus of the VAMP2 helix in postfusion state, which was deleted from the mimetic used here ( Fig. 2a-c, Supplementary  Fig. 3 ). In crystals of scCPX-F34M-SNARE, the interactions between CPX acc and the t-SNARE groove are as just described for the scCPX-SNARE crystals, in four of eight crystallographically distinct complexes. In the remaining four complexes, the binding site on the t-SNARE is shifted by approximately two helical turns, so that the interface between CPX acc and the t-SNARE is larger (~1,000 Å 2 versus ~715 Å 2 , Fig. 2b, Supplementary Fig. 3 ), additionally involving CPX residues Leu41, Ala44 and Arg48. Because a single mutation in the CPX acc sequence allows for two different binding modes, we expect that the high sequence variability in CPX acc of different complexins (isoforms 1-4 and in different organisms) results in slight variations of SNARE-bridging interactions and strength. The recurrence of the zigzag arrangement of CPX-SNARE complexes in two different crystal forms, however, supports the notion that this arrangement may be physiologically relevant.
Notably, for both scCPX and scCPX-F34M, residues that were mutated to make the superclamp CPX (D27L E34F or E34M R37A) are an integral part of the hydrophobic interface with the SNARE complex. The ability to bind the t-SNARE surface through a more extended hydrophobic interface may explain why the superclamp sequences have a higher affinity for prefusion SNARE complexes than wild-type CPX (shown below) and why superclamp CPX acc clamps more effectively in vitro and in vivo 19, 38 .
Solution studies confirm the CPX acc -SNARED60 interaction
In both the CPX-SNARE structures, we thus find CPX acc interacting with the t-SNAREs in such a way that CPX, linked by its central helix to one SNARE complex, blocks binding of the VAMP2 C terminus to another complex, cross-linking the SNARE complexes into an array in the process.
We used isothermal titration calorimetry (ITC) experiments to confirm that CPX acc interacts with the t-SNARE in prefusion The side chain of Lys26 is disordered in our structure, but functional data 19 suggest that it has a role in clamping. It may interact with the VAMP2 C terminus that is absent in our structure.
a r t i c l e s SNARE complexes. In these experiments, we used a complexin construct comprising both the central and accessory helices (residues 26-83) rather than a peptide corresponding to the accessory helix alone. Our rationale was that the accessory peptide does not fold into an α-helix, as monitored by circular dichroism (CD) spectroscopy, and thus does not fold as in the full-length protein, where it has high helical propensity (CD and ref. 39 ). The longer complexin construct was chosen to avoid complications in binding measurements resulting from folding energetics.
To observe the interaction between only CPX acc and the SNARE complex, we blocked the CPX cen binding site on either a fully assembled postfusion SNARE or SNARE∆60 by previously binding CPX cen (residues 48-134). Various CPX constructs were then titrated in to derive interaction affinities. As predicted from the postfusion SNARE-CPX crystal structure, we find no additional interaction between wild-type complexin (wtCPX, residues 26-83) and the blocked postfusion SNAREpin (Fig. 3a) . In contrast, wtCPX interacted with blocked SNARE∆60 with K d ~10 µM affinity, consistent with the presence of an additional, prefusion binding site only and with the finding that CPX competes with the VAMP2 C terminus for binding 19 . Further, the interaction affinity could be modulated by mutating residues in CPX acc , as expected if CPX acc participates in the interaction (Fig. 3b) . We used CPX mutants where residues at the CPX acc -SNARE interface in the crystal structure were altered. In addition to scCPX (D27L E34F R37A) we designed a nonclamping CPX mutant (ncCPX: A30E A31E L41 A44E) in which hydrophobic residues at the CPX acc -t-SNARE interface in the crystal structure were replaced by charged residues (Fig. 2c) . As expected, the binding affinity for scCPX was ~8-fold stronger than wild-type, consistent with the difference in activity observed for both in vitro and in vivo assays 19, 38 , whereas ncCPX no longer interacted with blocked SNARE∆60 (Fig. 3b) . Thus, binding studies corroborate an interaction between CPX acc -both wild-type and superclamp-and the prefusion SNARE complex, as observed in the crystal structure. We used fluorescence resonance energy transfer (FRET) experiments to establish that the angled conformation of CPX also occurs in solution and is therefore not dictated by crystal packing. The donor dye (stilbene) was attached to SNAP-25 residue 193, with the acceptor dye (bimane) positioned either at residue 31 or 38 of superclamp CPX (Fig. 4a ) (note that acceptor positions were placed so that they would interfere with CPX acc -t-SNARE cross-linking interactions, enabling monodisperse CPX-SNARE complexes to be studied). Distances estimated through quenching of donor fluorescence for CPX bound to the fully zippered SNARE complex correspond closely to distances observed in the crystal structure of the postfusion CPX-SNARE complex (PDB 1KIL), where CPX acc runs parallel to the SNARE complex ( Fig. 4b,c, Supplementary Table 3) .
In contrast, residues nearer the CPX acc N terminus appear to move increasingly away from the SNARE∆60 complex used for crystallization (so that the dye at CPX residue 31 is farther from the donor Fluorescence emission spectra of stilbene only (black) and stilbene-or bimane-labeled CPX-SNARE complexes containing VAMP2 (residues 25-96, red), VAMP2-∆60 (residues 25-60, cyan), or VAMP2-4X (residues 25-96 with mutations L70D, A74R, A81D and L84D to preclude zippering of the VAMP2 C terminus, blue). CPX is labeled with bimane at residue 38. (c) As in b, but CPX is labeled with bimane at residue 31. These data were used to calculate the distances shown in Supplementary Table 3. (d) FRET of a flexible CPX mutant (CPX-GPGP) in comparison to wild-type (WT) CPX when bound to prefusion (VAMP2-∆60) or postfusion (VAMP2) SNARE complexes. When the accessory helix is uncoupled from the central helix by a helix-breaking GPGP insertion, there is a complete loss of FRET signal with both SNARE complexes, different from the partial change in FRET observed with intact CPX. Thus, it is unlikely that differences between the FRET signals observed with intact CPX are due to random motion in CPX acc .
a r t i c l e s than the dye at CPX residue 38), and the distances estimated through quenching of donor fluorescence (see Supplementary Fig. 4 for comparable data for acceptor fluorescence increase and with a second FRET pair) agree with the angled conformation in the crystal structure (Supplementary Table 3, Fig. 4b,c) . Use of a 'flexible' CPX construct (CPX-GPGP), in which a helix-breaking GPGP linker was inserted between the central and accessory helices of CPX, discounts the possibility that the change in the FRET signal reflects random motion in CPX acc due to increased CPX flexibility rather than a discrete change in CPX conformation (Fig. 4d) . In contrast to the experiments with the undisrupted CPX constructs, there was no detectable FRET signal for CPX-GPGP bound to either SNARE∆60 or to the postfusion SNARE, consistent with random motion in CPX-GPGP but not for the intact CPX. To rule out the possibility that the angled conformation in solution results from VAMP2 truncation, we also studied and obtained similar results (Supplementary Table 3, Fig. 4b,c) for a complex containing the entire VAMP2 SNARE motif but harboring mutations in its C-terminal hydrophobic layers (L70D A74R A81D L84D) that prevent assembly of this region with syntaxin1 and SNAP25 and eliminate fusion activity 40 . These experiments indicate that when CPX is bound to a half-zippered form of the SNARE complex, CPX acc has the intrinsic property of extending away from the complex. Because this conformation is maintained in solution, it determines how the complex crystallizes and not vice versa. We thus conclude that as CPX rigidly extends away from the halfzippered SNARE complex, the only plausible way for both its central and accessory helices to interact with the SNAREpin is if CPX can interact with two different prefusion SNAREs, cross-linking SNAREs into an array like the zigzag one observed in the crystals.
Mutations in the CPX acc binding surface affect clamping
Further support that the CPX acc -t-SNARE binding interface observed in the crystal structure represents biologically relevant interactions comes from in vitro clamping assays. In these experiments, 'flipped' SNARE proteins were expressed on the cell surface, and the effects of CPX and synaptotagmin constructs on cell-cell fusion were monitored.
These flipped-SNARE cell-cell fusion assays were initially developed to demonstrate clamping by CPX and clamp release by synaptotagmin 4, 18 , and the effects of CPX mutations (including the superclamp mutations) in these assays are consistent with their effects in vivo 38 .
We systematically tested the effect of the mutations introduced in CPX acc and mapped residues that did or did not affect clamping onto the surface of CPX (Fig. 5a,b) . Mutations that were located at the CPX acc -SNARE interface observed in the structure all altered clamping efficiency. As expected, clamping was affected positively by scCPX mutations and negatively by ncCPX mutations (Fig. 5) . Mutations, used as a control, that were oriented away from the interface on the opposite side of CPX had no effect on clamping (Fig. 5) . These findings strongly support the possibility that the interface observed in the crystal contact is relevant for the physiological function of complexin and verify the rational of our mutant design for ITC.
We note, however, that although ITC and the in vitro clamping assays validate that CPX acc interacts with prefusion t-SNAREs using a surface similar to that identified from the crystal structure, it is likely-given the differences between the superclamp and wild-type sequences-that the details of the interaction differ for wild-type CPX. But as discussed earlier, owing to low sequence conservation in the accessory helix, there may also be variability in the interactions of CPX acc from different organisms.
The observations from the crystal structure and their agreement with FRET from monodisperse solutions suggest that the CPX accessory helix rigidly bends away from the SNARE complex. To test whether the rigidity of CPX is important for clamping, we again used the flipped SNARE cell-cell fusion assays. We used CPX mutants (CPX-GPGP, CPX-GGG) that had helix-breaking linkers (GPGP and GGG, respectively) inserted after residue 50, between CPX cen and CPX acc , as well as a construct where residues 51-53 at the central-accessory helix junction were replaced by glycines to disrupt the long CPX helix (see Fig. 5c ). Clamping should be affected if the continuity and hence rigidity of the CPX helix is mechanistically important. We found that clamping was indeed reduced in all three cases, consistent with the requirement for a continuous helix (Fig. 5a) . a r t i c l e s DISCUSSION Model for clamping Binding, fluorescence and functional studies all corroborate the conformation of CPX as observed in the crystal structure as well the newly identified interaction between CPX acc and the t-SNARE. Based on the crystal structure, we therefore propose that CPX directly cross-links presynaptic, prefusion SNARE complexes and, further, that the arrangement of CPX-SNARE complexes in the clamped state is similar to the zigzag one observed in the crystal lattice. Such an arrangement is plausible given the length of linkers that anchor the t-and v-SNAREs to the membranes, as the linkers for syntaxin1 and the half-zippered VAMP2 are longer than 10 (~37 Å) and 30 residues (>100 Å), respectively (Fig. 6a) . The number of CPX-SNARE complexes in the zigzag array would be limited owing to curvature in the vesicle, which increases the distance between the vesicle and plasma membranes with increasing distance from the fusion site (close to the zigzag array center), so that polymer extension beyond a certain distance is untenable. Previous experiments suggest that for optimal fusion rates, there are 5-10 SNARE complexes in a fusion pore 14 , which is allowed by our model.
The crystal structure naturally suggests several synergistic mechanisms by which CPX might stabilize the prefusion state and inhibit fusion ( Fig. 6) .
First, CPX acc binds the t-SNAREs in a site occupied by C-terminal portions of the VAMP2 SNARE motif in postfusion SNARE complexes, competitively blocking the completion of zippering by VAMP2 as proposed previously from biochemical studies 19, 34 but with the critical modification that this interaction occurs intermolecularly.
Second, close apposition of SNAREpins by cross-linking at their zippering ends should prevent further zippering that, if it occurred, would cause them to clash sterically (~2 turns of the N-terminal SNAP25 SNARE motifs are not folded in our structure).
Third, the linker regions of syntaxin1 and VAMP2 on different sides of the zigzag midline emerge on opposite sides of the zigzag plane, again, sterically interfering with complete zippering.
Fourth, the fusion pore cannot form as it is blocked by the CPX-SNARE zigzag array, which is interposed between the vesicle and plasma membranes. Our finding from functional assays that flexibility in CPX interferes with clamping suggests that the CPX-SNARE zigzag array must be rigid at least to some extent. The requirement for rigidity is consistent with a role as a barrier between membranes that are poised for fusion.
And fifth, cross-linking the SNARE complexes into a zigzag array prevents them from forming the circular arrangement needed to accommodate either a hemifusion stem 41 or a fusion pore 42 , precluding their formation. Notably, though, even in the zigzag topology, the orientation of the SNAREs is very similar to that in a fusion-competent arrangement (compare panels in Fig. 6b) , except that the cross-links must dissolve in order for fusion to take place. As the zigzag clamp disassembles and SNAREs zipper, steric repulsion would push the SNAREs radially away from the zigzag midline to form a circular arrangement (Fig. 6b) , now enclosing a nascent fusion pore that opens progressively as zippering completes 43 .
Though clearly vital for clamping 19 , each pairwise interaction between CPX acc and t-SNARE complexes seems of relatively low affinity (K d ~10 µM, corresponding to ~6.8 kcal mol −1 ). Nonetheless, binding with this affinity is likely to occur physiologically because the concentrations of CPX and SNARE proteins in the region local to fusion between apposed bilayers (~20 nm × ~20 nm × ~20 nm (Fig. 6a) containing 5-10 CPX-SNARE complexes 14 ) are likely to be in the 1-2 mM range (incidentally, an order of magnitude higher than their concentration in the crystallization mixture). Also, because of entropy considerations, polymerization would be more favored for proteins constrained to two dimensions, as at the synapse, rather than in solution.
The clamp may be further stabilized by the CPX N terminus, absent in our structure, which can interact with membrane proximal portions of SNAREs 20, 44 . Additionally, functional assays show that synaptotagmin ( Fig. 6a and ref. 45 ) in its calcium-free conformation stabilizes the clamped state produced by CPX 18, 46 , although how this occurs is currently unclear.
SNARE activation
As noted previously, in addition to its inhibitory role, CPX also has an important positive role in promoting fusion 21 . Some of the domains shown to be required for this mode of action 21, 24 are not present in our structure. It has been speculated, however, that one positive contribution may result from the binding of CPX cen to the VAMP2-syn-taxin1 interface, which would stabilize initial SNARE assembly and zippering 27, 29 . Our studies now suggest a similar role for the accessory helix: its interaction with the t-SNARE groove newly identified by us indicates that CPX might facilitate t-SNARE folding by binding to the C-terminal part of their SNARE motifs before VAMP2 binding.
Most importantly, we note that the assembled clamp itself might promote fusion by simply setting the stage: multiple SNARE complexes are gathered in orientations close to that required for fusion pore formation (compare panels in Fig. 6b ) even as their cross-linking impedes it, and they are already half-zippered. This alone will allow for fast, efficient fusion as soon as the clamp is released upon stimulus. Figure 6 Molecular models for CPX clamping. (a) Model for the clamp at the synapse. CPX-SNARE complexes with half-zippered VAMP2 are cross-linked by CPX into a zigzag topology incompatible with fusion (see text). The plane of the zigzag is normal to the vertical direction. For clarity, only two of the CPX-SNARE complexes in the zigzag are shown. Palmitoylation on SNAP25 is indicated and restrains the distance between the CPX-SNARE zigzag and the plasma membrane (PM). The distance between the zigzag plane and the vesicle (SV) must be less than ~110 Å, the maximum distance spanned by the v-SNARE linker. The calcium sensor synaptotagmin (gray with Ca 2+ -binding loops in orange), which relieves CPX clamping, is accommodated by this model and is positioned based on FRET analysis 45 . Its Ca 2+ -binding loops are juxtaposed to the vesicle membrane, which is rich in anionic lipids like phosphatidylserine, and is well positioned for interactions with this membrane in response to Ca 2+ The mechanism of clamp disassembly is further explored in an accompanying manuscript 40 , as is the finding that clamp release is intrinsically coupled to a conformational change in CPX, where CPX switches from the angled conformation observed in the CPX-SNARE∆60 structure to that in the postfusion CPX-SNARE complex 28, 29 .
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. Coordinates and structure factors for the structures described in this manuscript have been deposited in the Protein Data Bank (accession codes 3RK2, 3RK3, 3RLO).
